UK-Based Nanomedicine firm set plans to initiate a large phase II efficacy study in 2019

Fungal Nail Infection (Onychomycosis) is the most common nail disorder.1 Risk factors such as trauma, old age, diabetes, immunosuppression, tinea pedis, psoriasis, and family history are leading to an increased prevalence.2 Onychomycosis is characterised by [...]